PPI interaction network detected 10 hub gene signatures (RPS8, BMP4, SFN, TYMS, NOG, AK5, WNT11, RLN1, ARG1, and ACSL), which were associated with COVID-19 and AF and could be considered as candidates for prospective drug targets. This evidence concerns the gene RLN1 and COVID-19.